Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) Gross Margin (2020 - 2025)

Treace Medical Concepts' Gross Margin history spans 6 years, with the latest figure at 80.62% for Q4 2025.

  • For Q4 2025, Gross Margin fell 13.0% year-over-year to 80.62%; the TTM value through Dec 2025 reached 79.81%, down 56.0%, while the annual FY2025 figure was 79.81%, 56.0% down from the prior year.
  • Gross Margin reached 80.62% in Q4 2025 per TMCI's latest filing, up from 79.07% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 83.94% in Q4 2021 to a low of 79.07% in Q3 2025.
  • Average Gross Margin over 5 years is 81.03%, with a median of 80.82% recorded in 2021.
  • Peak YoY movement for Gross Margin: soared 785bps in 2021, then crashed -207bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 83.94% in 2021, then decreased by -2bps to 81.87% in 2022, then decreased by 0bps to 81.56% in 2023, then dropped by -1bps to 80.74% in 2024, then dropped by 0bps to 80.62% in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Gross Margin are 80.62% (Q4 2025), 79.07% (Q3 2025), and 79.67% (Q2 2025).